Japan

What to Expect for AstraZeneca in Fiscal 2018
What to Expect for AstraZeneca in Fiscal 2018
Market Realist
AstraZeneca
guidance
generics
Crestor
Japan
Europe
Flag link:
Astellas to pay Aquinox $25M upfront for regional rights to phase 3 inflammatory pain drug
Astellas to pay Aquinox $25M upfront for regional rights to phase 3 inflammatory pain drug
Fierce Biotech
Astellas
Aquinox Pharmaceuticals
SHIP1 activator
Japan
Asia
rosiptor
Flag link:
Myriad’s breast cancer diagnostic wins approval in Japan
Myriad’s breast cancer diagnostic wins approval in Japan
Drug Delivery Business News
Myriad Genetics
diagnostics
breast cancer
Japan
Bracanalysis Diagnostic System
Lynparza
Flag link:
Japan approves Novo Nordisk’s once-weekly Type II diabetes drug
Japan approves Novo Nordisk’s once-weekly Type II diabetes drug
Drug Delivery Business News
Japan
Novo Nordisk
diabetes
type 2 diabetes
Ozempic
Flag link:
Reimbursement Trends for Medical Devices in Japan
Reimbursement Trends for Medical Devices in Japan
Medical Devices and Diagnostics Industry
devices
Japan
reimbursement
Flag link:
Shionogi’s flu drug wins green light in Japan, but U.S. approval not likely until 2019
Shionogi’s flu drug wins green light in Japan, but U.S. approval not likely until 2019
Fierce Pharma
Japan
Shionogi
Flu
influenza
Xofluza
Flag link:
Shionogi, Roche get their first approval for the next big thing in fighting the flu
Shionogi, Roche get their first approval for the next big thing in fighting the flu
Endpoints
Shionogi
Roche
Flu
influenza
Xofluza
Japan
Tamiflu
Flag link:
Why Thailand is an Untapped Medtech Opportunity
Why Thailand is an Untapped Medtech Opportunity
Medical Devices and Diagnostics Industry
devices
Thailand
Japan
medical tourism
Flag link:
Drugmakers take to Japan: 3 new drug approvals won by AstraZeneca, Merck, and EA Pharma
Drugmakers take to Japan: 3 new drug approvals won by AstraZeneca, Merck, and EA Pharma
Endpoints
AstraZeneca
Lynparza
Merck
ovarian cancer
asthma
Japan
Fasenra
EA Pharma
elobixibat
Flag link:
Cancer Space Update: New Regulatory Status for 3 Major Drugs
Cancer Space Update: New Regulatory Status for 3 Major Drugs
Yahoo/Zacks.com
cancer
Merck
Japan
Keytruda
Seattle Genetics
Adcetris
Novartis
Kisqali
Flag link:
Bayer AG taps PeptiDream in billion-dollar deal
Bayer AG taps PeptiDream in billion-dollar deal
Endpoints
Bayer
R&D
Japan
PeptiDream
Flag link:
FDA, EMA and PMDA Plot Harmonized Path for Antibiotics
FDA, EMA and PMDA Plot Harmonized Path for Antibiotics
RAPS.org
FDA
EMA
PMDA
antibioitics
Europe
Japan
Flag link:
Why Do Alzheimer’s Drugs Fail? Japanese Researchers May Have Found an Answer
Why Do Alzheimer’s Drugs Fail? Japanese Researchers May Have Found an Answer
Xtalks
Alzheimer's disease
Japan
Flag link:
As CAR-T launch ramps up in U.S., Novartis' Narasimhan looks to convince Japan on performance-based pricing
As CAR-T launch ramps up in U.S., Novartis' Narasimhan looks to convince Japan on performance-based pricing
Fierce Pharma
Novartis
CAR-T
Vas Narasimhan
Japan
drug pricing
performance-based pricing
Flag link:
AstraZeneca's latest respiratory win could spur Bevespi approvals in China, Japan
AstraZeneca's latest respiratory win could spur Bevespi approvals in China, Japan
Fierce Pharma
AstraZeneca
Bevespi
COPD
China
Japan
Flag link:
Cytokinetics inches forward with heart failure program
Cytokinetics inches forward with heart failure program
BioPharma Dive
Cytokinetics
Omecamtiv Mecarbil
Amgen
heart failure
Japan
Flag link:
Tesaro partners with Takeda in Asia, bagging a $340M deal for Zejula
Tesaro partners with Takeda in Asia, bagging a $340M deal for Zejula
Endpoints
Tesaro
Takeda
Japan
Zejula
Flag link:
Resolute Onyx drug-eluting stent launches in Japan
Resolute Onyx drug-eluting stent launches in Japan
Drug Delivery Business News
Resolute Onyx
drug-eluting stents
Japan
Medtronic
devices
Flag link:
Japan May Prove to Be Strong Growth Driver for AstraZeneca in 2017
Japan May Prove to Be Strong Growth Driver for AstraZeneca in 2017
Market Realist
Japan
AstraZeneca
Tagrisso
Flag link:
Takeda teams up with venture firm on drug discovery unit
Takeda teams up with venture firm on drug discovery unit
BioPharma Dive
Takeda
drug discovery
drug development
R&D
Japan
Scohia Pharma
Flag link:

Pages